HONOLULU, June 15 /PRNewswire/ -- Nanopoint Inc., an award-winning developer of Microfluidics and Live Cell Imaging products, today announced that effective immediately its cellTRAY Imaging System and cellTRAY Fluidics System are available to the European marketplace. Nanopoint's cellTRAY Imaging and Fluidics Systems provide solutions to a broad spectrum of applications including drug discovery, assisted reproductive technology (ART), stem cell research, and cryobiology, as well as other areas where live cell culturing and analysis is important.
Nanopoint's fully integrated systems, which include its patented cellTRAY, automated microfluidics delivery system, on-stage incubator and imaging software were designed to enable multi-day live cell culturing and experimentation, provide robust data collection and utilize far less space on a scientist's bench top. Nanopoint's cellTRAY Systems create new standards of precision and levels of efficiency for the study of individual and small groups of live cells, enabling new approaches for multiple cell analysis and simultaneous processing, while supporting extended time lapse imaging of a wide variety of cell types.
The company's cellTRAY Imaging System Model CT-2000 and cellTRAY Fluidics System Model CT-2000F have successfully completed the safety certification testing necessary to complete its declaration of conformity, allowing the company to apply the CE mark to both products. "The application of the CE mark on our cellTRAY Systems is an exciting milestone and presents a tremendous opportunity for us, as it represents a key advancement into the international commercialization of our products," said Cathy Owen, CEO of Nanopoint, Inc.
The cellTRAY Imaging System Model CT-2000 for drug discovery applications contains a patent-pending on-stage incubator and microfluidic delivery system enabling extended time-lapse imaging of live cells. The system, an add-on to an i
|SOURCE Nanopoint Inc.|
Copyright©2009 PR Newswire.
All rights reserved